Answers are grounded in this paper and cite their sources.
Abstract A comprehensive polyphasic characterization validated the unique taxonomic position of a novel bacterium, strain EMC7T, isolated from the worm castings of earthworm, Eisenia fetida. This Gram-negative, facultatively anaerobic, motile rod-shaped bacterium showed maximum sequence homology with Leclercia adecarboxylata NBRC 12595T, placing it within the genus Leclercia. The genome of EMC7T is 5.03 Mbp with a G + C content of 56.3 mol%. Phylogenetic analyses established its distinctiveness from Leclercia adecarboxylata and Leclercia tamurae. DNA-DNA hybridization (dDDH) value was 23.6%, and the average nucleotide identity (ANI) was 82.1%, both below the thresholds for prokaryotic species differentiation. The predominant fatty acids were C16:0 (29.53%), summed feature 3 (C16:1ω7c/C16:1ω6c, 16.51%), and C18:1ω7c (10.90%). Notably, EMC7T exhibited urease activity and could metabolize 3-nitropropionic acid (3-NPA), glycerol, tellurite, selenate, and selenite, suggesting potential bioremediation applications. Biochemical tests, phenotypic traits, genotypic data, and physiological properties cumulatively differentiated EMC7T from its closest relatives. Based on chemotaxonomic, phenotypic, genomic, and phylogenetic evidence, strain EMC7T represents a novel bacterial species of the genus Leclercia, for which the name Leclercia barmai sp. nov. (type strain EMC7T = MCC 5183T = JCM 36544T) is proposed.
No takes yet. Share an insight, caveat, or question.
Barman et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: